Cancer Conferences | Oncology Conferences | Cancer Therapy Meeting | 30th Experts Meet on Cancer Therapy 2018 | Melbourne | Asia Pacific | USA | Europe | Middle East | 2018

Quick Links

Homepagebanner_CancerTherapyMeeting2018

Cancertherapymeeting2018_HomepageBanner

Theme: Sensible assembly on emerging prospects of cancer therapy

Cancer Therapy Meeting 2018

Conference Program

Renowned Speakers

Ozge Akbulut
Sabanci University
Turkey

Lei Huo
University of Texas
USA

Alok De
Kansas City VA Medical Center
USA

Diana Anderson
University of Bradford
UK

Alvaro Macieira-Coelho
INSERM
France

Bo Yuan
Tokyo University of Pharmacy & Life Sciences
Japan

Larysa Skivka
Taras Sevchenko National University of Kyiv
Ukraine

Han Xiao
Wuhan Medical and Health Center for Women and Children
China

Leung K N
The Chinese University of Hong Kong,
China

Sadir Alrawi
Alzahra Cancer Center
UAE

Tarek Dufan
American Hospital Dubai
UAE

Sonya Sergieva
Sofia Cancer Center
Bulgaria

Cancer Therapy Meeting 2018

30^th Experts Meet on Cancer Therapy

Dates: November 14-15, 2018

Venue: Melbourne, Australia

Theme: Sensible assembly on emerging prospects of cancer therapy

ConferenceSeries llc LTD invites all the participants from the world to attend the “30^th Experts Meet on Cancer Therapy” which gathers all the people to share their knowledge and have a discussion on the current issue on cancer and development of cancer therapies.

About:

Conference series llc LTD organizes 300+conferences, 500+workshops and 200+ Symposiums on different branches like clinical, medicine, pharmaceutical sciences & Technologies every year from all over the world U.S.A, U.K, U.A.E, Singapore, Malaysia, Korea, Australia, India, Indonesia and from 1000 more scientific societies and published 500 open access journals with 30000 eminent personalities & reputed scientists as editorial members.

Who should attend?

Cancer Therapy Meeting 2018 is an expertise meet in the field of oncology where oncologists, scientists, researchers, medical students, pharmacists, R& D scholars, medical professors, gynecologists, molecular biologists, bioinformatics students and professors, radiologists, cancer research institutes to exchange ideas, communicate & discuss the research work and about new advancements in the cancer therapy and treatment.

Why in Australia?

Before the age of 75 cancers are diagnosed about 1 in 3 Australian men and 1 in 4 Australian women. Maximum of the people living in Australia will be touched with cancer at some stage of their lives by personally or in the form of family or friends. More than 1,23,000 new cases of cancer are diagnosed in Australia annually. Commonly diagnosed cancers in Australia are prostate cancer, colorectal cancer, and breast cancer, melanoma of skin and lung cancers. These cancers accounts for about 60% of all cancers diagnosed in Australia.

Cancers that are diagnosed most in particular age groups;

Leukemia for people aged 0-24
Breast cancer for women and melanoma for men aged 25-49
Prostate cancer for men and breast cancer for women aged 50-64
Colorectal cancer for people aged 65 and above

Target audience

Oncologists
Radiologists
Haematologists
Gynaecologists
Dermatologists
Biotechnology students
Bioinformatics students
Research scholars in cancer
R&D department in pharmacy
Robotic science researchers
Cancer research institutes
Professors & Students from cancer research centers
Cancer research universities in Asia-pacific regions

Why to attend?

With delegate scientists, renowned speakers from all over the world we are gathering people from all over the globe to have a spectacular conference at one place. This is the best opportunity to reach the largest assemblage of participants from the different branches that are working on the cancer therapy to reduce the mortality rate by providing the highly effective therapy to the cancer patients.

Speakers will include world renowned experts in all disciplines, offering a unique opportunity to highlight new technologies in all aspects of cancer therapy.

Benefits:

All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.
Each abstract will receive a DOI number provided by Cross Ref
Opportunity to conduct Workshop with your team members
One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Certification by the organizing committee.
Individual keynote Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.

30^th Experts Meet on Cancer Therapy

Dates: November 14-15, 2018

Venue: Melbourne, Australia

Theme: Sensible assembly on emerging prospects of cancer therapy

ConferenceSeries llc LTD invites all the participants from the world to attend the “30^th Experts meet on cancer therapy” which gathers all the people to share their knowledge and have a discussion on the current issue cancer therapy.

Who should attend?

Target audience

Oncologists
Radiologists
Haematologists
Gynaecologists
Dermatologists
Biotechnology students
Bioinformatics students
Research scholars in cancer
R&D department in pharmacy
Robotic science researchers
Cancer research institutes
Professors & Students from cancer research centres
Cancer research universities in Asia-pacific regions

Why to attend?

With delegate scientists, renowned speakers from all over the world we are gathering people from all over the globe to have a spectacular conference at one place. This is the best opportunity to reach the largest assemblage of participants from the different branches that are working on the cancer therapy in order to reduce the mortality rate by providing the highly effective therapy to the cancer patients.

Speakers will include world renowned experts in all disciplines, offering a unique opportunity to highlight new technologies in all aspects of cancer therapy.

Benefits:

All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.
Each abstract will receive a DOI number provided by Cross Ref
Opportunity to conduct Workshop with your team members
One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Certification by the organizing committee.

Individual keynote Page will be created to get more visibility for your scientific research.

Huge Benefits on Group Registration and much more.

Track: 1 Cancer

Cancer is the abnormal growth of cells, which may be benign or malignant that spreads or occupy near-by tissues. As these tumors grow, some of the cancer cells break and move to distant places in the body through circulating fluids (blood & lymph). Uncontrollable growth of cells and division which they get easily invaded in to other cells or tissues of the body resulting in modifying a healthy cell to cancer cells. The agents that cause cancer are said to be carcinogens. The cancer cells present in the body do not die and leading to formation of excess cancer cells in the body resulting in forming mass of tissue, called tumor. Benign tumors don’t invade or spread to other tissues. In case of malignant tumors these invade and spread to other parts of the body rapidly.

Related conferences: Cancer conferences | Oncology conferences | Therapy Conferences

2nd Global Summit on Oncology & Cancer, March 12-14, 2018 Singapore. 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2018 Rome, Italy. 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2018 San Diego, CA. 26th Annual Congress on Cancer Science and Targeted Therapies, October 29-30, 2018 San Francisco, California, USA. 2nd International Conference on Cancer Genetics and Epigenetics, November 12-13, 2018 Tokyo, Japan. Japanese Society of medical oncology 16^th annual meeting 2018 July 19-21, 2018 Kobe, Japan. ECCO 2018: European Cancer Summit September 7-9, 2018 Vienna, Austria. International Conference on Cancer Nursing (ICCN) 2018, September 23-26, 2018 Auckland, New Zealand. 2018 NCRI Cancer Conference November 4-6, 2018 Glasgow UK. TAT 2019- International Congress on Targeted Anticancer Therapies February 25-27, 2019 Paris, France

Track: 2 Most prevalent cancers

The most prevalent cancers in the world by comparing to the men and women are lung cancer is the most prevalent cancer of all the cancers. The most common cancers occurring in men are lung cancer, prostate cancer and Colo-rectal cancers occupying about 43% of the cancers occurring in men. The other common cancers in men are stomach and liver cancers. In case of women most common cancer in the world is breast cancer of about 25% of cancers that are occurring in women are breast cancers. Next to the breast cancer Colo-rectal cancer, lung cancer and cervical cancer are most prevalent in women. The common reason behind cancer is physical carcinogens, chemical carcinogens and biological carcinogens. Usage of tobacco and alcohol consumption is the main common cause of lung cancer.

22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan. International Conference on Cancer Diagnosis & Treatment, August 2-3, 2018 Oslo, Norway. 36th World Cancer Conference, October 11-13, 2018, Switzerland. 30th International Conference on Cancer Research and Therapy, November 12-13, 2018 Osaka, Japan. 3rd Cancer Diagnostics & Treatment Conference, November 29-December 01, 2018 Dublin, Ireland. 28^th Annual Mayo Clinic Hematology/Oncology Reviews 2018 August 1-4, 2018 Amelia Island, United states. 1^st Oncobell Symposium: Mechanism of Cancer and new Therapeutic Strategies September 20-21, 2018 Barcelona, Spain. Imaging and Therapeutic Targeting in Cancerology: New advances and trends in preclinical and clinical studies September 26-29, 2018 Le Bono, France. European Society for Medical Oncology Congress 2018 October 19-23, 2018 Munich, Germany. ESMO Immuno- Oncology Congress 2018 December 13-16, 2018 Geneva, Switzerland.

Track: 3 Cancers Stages

Stage of cancer can be described by the extent of growth of cancer and based on size of cancer. Stage of cancer can be found be found by performing the tests. By these tests we can know even the extent of spread of cancer and how far it has spread to other adjacent organs. Staging of cancer should be clearly understood by the doctor so that the type of treatment to be given could be easily known. If the cancer is present at only one place then treatment like surgery or radiotherapy is sufficient to get rid of cancer completely. If there is spread of cancer to adjacent organs, then the treatment to be given in such a way that it circulates the whole body. There will not be correct identification of cancer sometimes then doctors check the lymph nodes present near to the cancer for the presence of cancer cells, it is the sign that indicates that the cancer has begun to develop I body.

There are 2 types of staging systems of cancer,

TNM system

Number system

T determines the size of cancer and how far cancer has spread to the adjacent tissues, in this there are 4 stages based on their increasing order.

N determines the spread of cancer to lymph nodes, in this there are 3 stages starting with 0 to 3 in which 0stage is the absence of cancer cells in lymph nodes and 3 stage is presence of cancer cells in the lymph nodes.

M stage is to determine the spread of cancer to other parts of the body it can either be 0 or 1.

Track: 4 Cancer Causes

Changes that occur in DNA with in the cells leads to cancer. DNA present in the cell is packed into huge number of individual genes; each of the individual genes contains a set of instructions that are to be performed by the cell. If the changes occur in the instructions, then it alters the cell function and makes the cell cancerous.

Gene mutations can direct a healthy cell to

Allow rapid growth
Fail to stop uncontrolled cell growth
Make mistakes while repairing DNA errors

Changes in behavioral and environmental characters also cause changes in the body’s cells which converts the healthy cells to cancer cells. 90-95% cancers are due to environmental factors and some cancers are due to inherited genetics. Cancers are also caused due to changes in the life style, economic and behavioral characters and due to pollution. Environmental factors that contribute to increase mortality rate of cancer patients includes tobacco, diet and obesity, infections, radiation, stress, lack of physical activity and pollution. Agents that have been linked to cause of cancers are said to be carcinogens. About 90% of lung cancers are due to smoking. Tobacco smoke also causes cancer in larynx, head, neck, stomach, bladder, kidney, esophagus and pancreas. Lung cancer and mesothelioma also can be caused due to inhaling tobacco smoke, asbestos fibers and leukemia from exposure to benzene. Absence of physical activity also contributes to causing cancer not only due to body weight also due to effects of immune system & endocrine system. I take of high salt food leads to gastric cancer. 18% of cancer deaths are due to infectious diseases. Human papilloma virus causes cervical cancer and hepatitis B and C virus causes hepatocellular carcinoma. 10% of cancers are due to exposure to radiation like ionizing radiation and non-ionizing ultraviolet radiation.

Related conferences: Cancer Conferences | Oncology conferences | Therapy Conferences | Causes of Cancer Conferences

Track: 5 Signs and Symptoms of different cancers

Signs and symptoms of cancers depend on the type of organ affected, size of the tumor and extent of cancer invaded. As the size of the tumor increases it pushes the nearby organs, tissues, blood vessels and nerves. Signs and symptoms of cancer cannot be found out every time, it depends on the type of organ affected, and some of the organs affected by cancer don’t show any signs and symptoms. Cancer in pancreas doesn’t show any signs and symptoms till most of the organ is affected and has even invaded the adjacent organs. Tumors may grow around the bile duct and resist the flow of bile. Then signs and symptoms include eyes and skin looks yellow. By that time of detection of pancreatic cancer, it would be in an advanced stage.

Some of the signs and symptoms of the cancer includes

Breathlessness
Unexplained vaginal bleeding
Persistent heartburn
Looser poo
Persistent bloating
Difficult in swallowing
Sore that won’t heal
Mouth and tongue ulcer that won’t heal
Heavy night sweats
Unusual breast changes
Unexplained weight loss
Coughing up blood
Persistent cough
Unexplained pain or ache
Unusual lump or swelling anywhere

Track: 6 Natural methods for treatment of cancer

Natural medicine aims to restore body’s ability to protect, regulate and heal itself. This looks at your physical, mental and emotional wellbeing. It is also called as phytomedicine, phytotherapy or botanical therapy. Alternative therapy that is followed by the cancer patients is herbal medicine. The physical examinations done by herbalists are,

Feeling pulse
Taking blood pressure
Examining skin and nails
Feeling abdomen
Looking at tongue

Track: 7 Management of cancer

Cancer can be managed based on stage of cancer, extent of spread of cancer and performance of cancer patient. Cancer treatment is the complete uptake of cancer from the body without showing affect to rest of the organs in the body. The treatment programs are those:

Those are provided in equitable and sustainable way
Those are linked to early detection and accurate diagnosis and staging
To adhere to evidence-based standards of care.

For the effective therapy the treatment programs should ensure timely and equitable access. Critical step in the management of cancer is to establish the diagnosis based on pathological examination. Tumor sample can be achieved by biopsy or aspiration which may also require an intervention such as image guided procedure or endoscopy.

Track: 8 Oncology Nursing

There are various types of nurse care associated with cancer treatments. Authority medical attendants, Ward medical care takers, Community medical care takers, Specialist palliative care medical attendants, Marie Curie Cancer Care Nurses. Authority attendants work primarily in doctor's facilities; however, some give mind in the patient's home. They may have some expertise in a particular malignancy for instance bosom, lung, head and neck disease, or a specific treatment, for instance chemotherapy. Community attendants give an extensive variety of nursing care including helping patients when they leave clinic, taking out fastens, wiping wounds and giving out some prescription at home. Authority palliative care medical care takers have skill in overseeing torment and different manifestations and can offer help for individuals with growth and their families
The propelled Oncology Nurse is ace's readied nurture with learning and limit in a scope of danger nursing. Every single medicinal overseer moves along a path from students to ace. It is seen that, paying little regard to paying little mind to the likelihood that a generalist, particular oncology or pushed Oncology Nurse, each individual therapeutic chaperon will experience along these lines from beginners to ace.

Track: 9 Molecular Pathology
Molecular pathology is an emerging discipline within pathology which is concentrated in the study and conclusion of ailment through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology imparts a few parts of practice with drug development, disease management strategies and is sometimes considered a crossover discipline. It is multi-disciplinary in nature and concentrates primarily on the sub-minute parts of diseases. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues and on molecular testing of diseases like cancer.

Related conferences: Cancer Conferences | Oncology conferences | Therapy Conferences | Causes of Cancer Conferences

Track:10 Cancer Genetics and Epigenetics

Epigenetics deals with the study of heritable changes in gene, that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes. The study of epigenetic modifications to the Cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence.

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics.

A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.
During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutations. Their manipulation brings a great promising approach to for preventing, detecting and treatment of cancer

Track: 11 Surgery

Surgery is the removal of tumor and the adjacent tissues affected with tumor at a time. Surgical oncologist is a person who specializes in treating cancer using surgery. There are goals for the cancer surgery they include,

To diagnose cancer
To remove some or all the cancer
To find out where the cancer is located
To find out the cancer has spread or is affecting the functions of other organs in the body
To restore the body’s appearance or function
To relieve side effects

For most of the cancers, biopsy is only the way to make a definitive diagnosis. At the time of surgical biopsy, the surgeon makes a cut called incision on the skin. The 2 main surgical biopsies include

1. An incisional biopsy- it is removal of piece of suspicious area for examination.

2. An excisional biopsy- it is the removal of entire suspicious area, such as mole or a lump.

After the biopsy a pathologist uses a microscope to examine the tissue removed and does laboratory tests for evaluating cells, tissues and organs to diagnose disease and provide a pathology report to the oncologist or the surgeon who performs the diagnosis.

Track: 12 Robotic Surgery

Robotic surgery is a type of minimally invasive surgery. “Minimally invasive” means that instead of operating on patients through large incisions, we use miniaturized surgical instruments that fit through a series of quarter-inch incisions. Cancer Sciences and Robotic Systems are very closely associated as the robotic technology enables the radiation oncologists to deliver high doses of radiation with pinpoint accuracy to a broad range of tumors throughout the body, including the lungs, prostate and pancreas.

When performing surgery with the da Vinci Si—the world’s most advanced surgical robot—these miniaturized instruments are mounted on three separate robotic arms, allowing the surgeon maximum range of motion and precision. The da Vinci’s fourth arm contains a magnified high-definition 3-D camera that guides the surgeon during the procedure. The system’s sophisticated software allows for tracking of the tumor and the ability to continually adjust the radiation treatment to account for patient or tumor movement.

Track: 13 Bio-engineering and Bio-mechanics in Robotics

Recovery mechanical autonomy is a field of research devoted to comprehension and expanding restoration using automated gadgets. Restoration apply autonomy incorporates advancement of automated gadgets custom fitted for helping distinctive sensorimotor functions, improvement of various plans of helping remedial training, and evaluation of sensorimotor execution of patient; robots are utilized principally as treatment helps rather than assistive devices. Rehabilitation utilizing mechanical technology is by and large all around endured by patients and has been observed to be a successful subordinate to treatment in people experiencing engine weaknesses, particularly because of stroke. Restoration mechanical technology can be viewed as a particular concentration of biomedical building, and a piece of human-robot connection. In this field, clinicians, specialists, and architects work together to help restore patients. Conspicuous objectives in the field include: creating implementable advances that can be effectively utilized by patients, specialists, and clinicians; improving the viability of clinician's treatments; and expanding the simplicity of exercises in the day by day lives of patients.

Track: 14 Radiation therapy

High- energy radiation is used in radiation therapy in order to shrink (reduce) the cancer cells or kill the cancer cells. X-rays, gamma rays and charged particles are the radiations used for cancer treatment. Radiation is sent to the body externally called external-beam radiation therapy and if the radiation comes from radioactive material placed in the body near cancer cells it is called internal radiation therapy or brachytherapy. Radioactive iodine that travels in the blood to cancer cells is systemic radiation therapy. More than half the amounts of people receive radiation therapy sometime at the course of treatment. Radiation therapy is done by damaging the DNA of cancer cells, in which it can damage the DNA directly or create free radicals within the cells that can in-turn damage the DNA.

Radiation oncologist’s plans a patient’s treatment through a process called treatment planning, that begin with simulation. At the time of simulation detailed imaging scans show the location of the patient’s tumors and the normal adjacent areas. There is different scanning equipment for treatment planning in radiation therapy.

Track: 15 Immunotherapy

Immunotherapy also said to be biologic therapy is a cancer treatment designed to boost the immune system to fight against cancer. It uses substances that are in the body or in the laboratory to improve or restore immune system function.

Types of immunotherapy includes

When there is any entry of foreign organism in to our body then body’s immune system detects the harmful organism and produces antibodies. Antibodies fight against infection. Monoclonal antibodies can be made in the laboratory. Monoclonal antibodies can be used for targeted therapy to block an abnormal protein in cancer cell.

Track: 16 Hormonal therapy

Some breast cancers are caused due to the hormones in blood. It is a form of systemic therapy it not only reaches the cancer cells present in breast also reaches cancer cells all over the body. Hormonal therapy is recommended for women with hormone receptor-positive breast cancers, it is not useful for the women who are suffering with hormone receptor-negative breast cancer.

Hormonal therapy is often used as adjuvant therapy to reduce the risk of cancer coming back. Sometimes this therapy is started as neoadjuvant therapy. The drugs that stop estrogen from affecting breast cancer cells are,

Tamoxifen
Toremifene
Fulverstrant

Related conferences: Breast Cancer Conferences | Breast Cancer Symposiums | Hormone Therapy Conferences

Track: 17 Artificial Intelligence in Cancer Treatment

The territories where automated frameworks are executed have been spreading progressively, other than classical applications in modern/creation fields and innovations, for the most part into the regions and advances with non-modern/non- designing applications, additionally into new regions of administrations These patterns put higher requests on the intricacy of advancement of all methods entering robotized creation and administration frameworks. Late patterns framed new needs on the advancement and development of new classifications and eras of robots and in addition new way to deal with the application of robots in view of higher advancement of computerized/automated frameworks adapted by profoundly unmistakable usage of non-conventional mechanical standards of control/PC innovation, data innovation and counterfeit consciousness. Robot-assisted surgery when indicated for oncology patients offers various unique advantages. The enhanced precision and control offered by the robot allows surgeons to perform delicate procedures like prostate surgery while preserving the nerve fibres and blood vessels attached to the gland. The enhanced vision of the surgical field offers surgeons the ability to clearly differentiate between tissue planes and effect precise tumor removal.

Track: 18 Clinical Trials in Cancer Treatment

l trials are the final step in a long process that begins with research in a lab. Before any new treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the lab and in animals. They also try to figure out the side effects it may cause.

Related conferences: Cancer Conferences | Oncology conferences | Therapy Conferences | Clinical trials in cancer treatment

Description

Global cancer therapies market (2016-2021)

By 2021 global cancer therapy market is estimated to reach $52.2 billion with a rise in 17.6% CAGR. And by 2016 it has reached $30.8 billion with CAGR of 15% in the global cancer therapy market.

Due to the rise in cancer incidences and entry to modern therapeutics, aged people in the population, huge innovations, improvements promote growth of the market, high efficacy and high process magnetize producers also contribute to the growth of the market. Major drawbacks are due to expensive therapies, change in reimbursement policies and the challenges faced in the clinical trials.

Market is divided based on the therapies;

Targeted cancer therapies

Hormone therapies

Immunotherapy

Chemotherapy

Therapies strategies

Cancer can be managed with different therapies of them gene induced therapy is a procedure intended to treat a disease by genetically modifying the cell of the patient. Genes, gene segments or oligonucleotides are transferred into patient cells. Gene transfer therapy can be done either in vivo approach or ex vivo approach. Gene therapy aims to modify, delete or replace abnormal gene of the target cell. Target cells may be malignant primarily or metastatic nodules, circulating tumor cells or dormant stem cells or specific cells such as T-cell lymphocytes or dendritic cells.

Oncolytic virotherapy shows improvement in the cancer patients who suffered a non-related viral infection or who are vaccinated earlier. It largely attributed to the production of interferon and tumor necrosis factors in response to viral infection, but Oncolytic viruses are being designed to lyse only cancerous cells.

Graphical statistics for different therapies of cancer.

Cancer associations in the world

American cancer society
American childhood cancer organization
Acoustic neuroma association of Australia
American gastroenterologist association
Association of international cancer research
Association for the study of lung cancer
Association of community cancer centers
Association of population-based cancer registers in Germany
Australian association of smoking cessation professionals
Australian prostate cancer research
Avon breast cancer crusade
Bangladesh cancer society
Breast screen Australia program
Bulgarian cancer association
Canadian association of pharmacy in oncology
Canadian cancer society
Cancer association of South Africa
Cancer council Australia
Cancer research institute
Cancer research UK
Cancer society Brazil
Children’s cancer association
Children’s cancer and leukemia group
Dutch cancer society
Dutch cancer registry
Egypt cancer society
European organization for research and treatment of cancer
Foundation for women’s cancer
French cancer society
German cancer society
German society of radiation oncology
Health Canada
Hong Kong Neuro-oncology society
Indian cancer society
International agency of research and cancer
International lung cancer consortium
Japan lung cancer society
Kidney cancer association
Korean cancer association
Leukemia & lymphoma society
Lung cancer Canada
Ministry of health – Armenia
National brain tumor society
National cancer institute
National lung cancer partnership
Oral cancer foundation
Ovarian cancer Australia
Pancreatic cancer action network
Prostate cancer Canada
Saudi oncology society
Singapore cancer society

Pharmacy companies dealing with cancer drugs

Roche
Novartis
Celgene
Johnson & Johnson
Bristol-Myers Squibb
Lilly
Takeda
AstraZeneca
Merck & co
Amgen
Pfizer
Astellas
Bayer
Otsuka
Sanofi

Cancer hospitals in Melbourne

Peter MacCallum Cancer Centre
Peninsula Oncology Centre
The Alfred hospital
Royal Melbourne hospital
Monash Medical Centre
Maroondah Hospital
Cabrini Hospital
Frankston Hospital
William Buckland Radiotherapy Centre
Box Hill Hospital
Melbourne Private Hospital
Epworth Hospital
Linacre Private Hospital
St Vincent's Hospital
Western Hospital
Warringal Private Hospital
Freemasons Hospital
Austin Health
John Fawkner Private Hospital
Ringwood Private Hospital

Medical universities in Australia

Australian national university medical school
Sydney medical school
University of New South Wales faculty of medicine
Western Sydney University School of medicine
University of Wollongong graduate school of medicine
University of Newcastle School of medicine and Public Health University of new England School of rural medicine
University of Notre dame school of medicine, Sydney
Bond university faculty of health sciences and medicine
Griffith university school of medicine
James Cook university school of medicine and dentistry
University of queen’s land school of medicine
University of Adelaide medical school
Flinders university school of medicine
Melbourne medical school
Monash University of faculty of medicine, nursing and health sciences
Deakin University School of medicine
University of Notre Dame
University of Western Australia
Curtin University

Medical universities in Melbourne

Australian National University Medical School
University of Melbourne
Monash University
Deakin University
The University of Western Australia
Curtin University
University of Newcastle School of Medicine
University of Tasmania
University of New England
Flinders University
University of Adelaide
University of Queensland
Griffith University
James Cook University
University of Notre Dame
University of Wollongong
Western Sydney University School of Medicine
Sydney Medical School
The University of New South Wales

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 14-15, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

Testimonials

This was really a remarkable conference from oncologists 2016 where new advances and some new methods and techniques looking in cancer were discussed in the meeting. I find this conference always very interesting, these people comes from all over the world, The presentation are usually very good, I think itâ€™s very useful and worth full to attend omics conferences.
Diana Anderson, University of Bradford, UK

I am glad to participate at Oncologists 2016 here at cologne, Germany. I am glad to participate at this great meeting with very interesting talks from physician and expertise all over the world, and I have enjoyed each and every session.
Stephanie Notttrott, Isenbruck BÃ¶sl HÃ¶rschler LLP, Germany

The conference was very interactive and quite interesting, as I have come from all the way from North Carolina to attend this conference, I have enjoyed every bit of learning new sciences in the field of oncology which is my research field. I am very grateful to the organizer especially omics for inviting me and giving me a chance to present my research work here at oncologists 2016, Cologne, Germany.
HirendraNath Banerjee,Elizabeth City State University, USA

I am very pleased about this conference because the session designed was based upon both scientific and in general and mode where we can discuss and express our views about it, I love and appreciate this type of conferences.
Apollon Karseladze, N. Blokhin Cancer Research Center, Russian Federation

I really enjoyed some of the talks and meeting people from all over the world, I am very happy to be a part of this great meetings. The major interaction of this conference was about oncology what I like the about this conference was the scientific sessions and this represents various countries.
B R Das, Research and Development, SRL Ltd., India

Thanks for arranging such amazing meeting.I am lucky to be one of the speaker in the meeting.
Wen-Lung Ma, China Medical University Hospital, Taiwan

Thank you for the greeting and we do learn a lot form this meeting in Cologne.
CSL in,National University,Taiwan

30^th Experts Meet On Cancer Therapy November 14-15, 2018 Melbourne, Australia

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com